• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • WCW HOME
  • Submit a Wire!
  • Advertising
  • Media Partners
  • About
  • Contact Us

WorkCompWire

Your Trusted Source for Workers Compensation News

Enlyte
  • Workers Compensation News
    • Workers Compensation Industry News
    • Association, Rating & Research News
    • Claims, Legal, & Compliance News
    • Legislative & Regulatory News
    • Risk Management News
    • Work Force & Human Resource News
  • Featured Articles
  • Leaders Speak
  • Editor’s Forum
  • People On The Move

Physician Dispensing & Opioids Still Major Concerns, Compounds an Emerging Issue

December 17, 2014 - WorkCompWire

Tampa, FL – Drug costs still worry workers’ compensation payers, despite relatively flat pharmacy costs, according to the results of CompPharma’s annual survey report of Prescription Drug Management in Workers’ Compensation.

Answering the question “How big of a problem are drug costs?” on a scale of 1-5 with 3 being “Drug costs are equally as important at other medical cost issues,” respondents put drug costs at 4.1. A slight increase over the past three-year average of 3.8, it indicated drug costs were more important than other medical cost issues. Respondents also predicted drug costs would be more of problem in the next two years than they are now.

Specifically, payers’ concerns circulated around opioids/narcotics, physician dispensing, and the emerging issue of compounded drugs. Physician dispensing, which accounted for more than 35 percent of the drug costs in 2013, raised specific concerns. Respondents cited patient safety because these drugs bypass the drug utilization review process and offer potential for duplicate therapy. All respondents pointed to higher costs. Repackaged drugs are priced higher than the same medications at retail stores; studies show extended disability duration and higher overall medical costs associated with physician dispensed drugs; and often the medication is unnecessary or not related to the claimant’s work injury.

When asked how to addresses these issues, respondents mentioned programs, legislation and regulation. “They seem to believe that without the legal backup provided by regulations or legislation, payers cannot effectively address certain concerns,” said CompPharma President Joe Paduda, noting that one person called for regulatory action regarding the use of strong utilization review coupled with evidence-based guidelines and tight formularies.

“There’s a sense that jurisdictions haven’t kept pace with medical developments, the explosion in the use of opioids or the creativity of repackagers and physicians seeking to maximize profits and the expense of tax payers and employers,” he added.

The 11th annual report can be found here: CompPharma: Prescription Drug Management in Workers’ Compensation Survey Report (PDF)

Source: CompPharma

Filed Under: Association, Rating & Research News, Industry News, Top Stories, Workers' Compensation

Primary Sidebar

Get Our Free Newsletter:

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: WorkCompWire.com, PO Box 1114, Culver City, CA, 90232, http://www.workcompwire.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

myMatrixx

Paradigm

MSQ

Follow Us on Twitter

Tweets by WorkCompWire

Workers Compensation News Topics

  • Top Stories
  • Featured Articles
  • Leaders Speak
  • Editor’s Forum
  • The RxProfessor
  • Industry News
  • Association, Rating & Research News
  • People On The Move
  • Claims, Legal, & Compliance News
  • Legislative & Regulatory News
  • Risk Management News
  • Work Force & Human Resource News
  • Workers’ Compensation

Wire Archives

Copyright WorkCompWire © 2023